SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001178913-22-002169
Filing Date
2022-05-25
Accepted
2022-05-25 15:24:54
Documents
17
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A zk2227905.htm   iXBRL 20-F/A 53168
2 EXHIBIT_1-1 exhibit_1-1.htm EX-1.1 302493
3 EXHIBIT_12-1 exhibit_12-1.htm EX-12.1 4432
4 EXHIBIT_12-2 exhibit_12-2.htm EX-12.2 4089
9 GRAPHIC img01.jpg GRAPHIC 89459
  Complete submission text file 0001178913-22-002169.txt   780264

Data Files

Seq Description Document Type Size
5 XBRL DEFINITION FILE trib-20211231_def.xml EX-101.DEF 19613
6 XBRL LABEL FILE trib-20211231_lab.xml EX-101.LAB 26635
7 XBRL PRESENTATION FILE trib-20211231_pre.xml EX-101.PRE 22187
8 XBRL SCHEMA FILE trib-20211231.xsd EX-101.SCH 5044
11 EXTRACTED XBRL INSTANCE DOCUMENT zk2227905_htm.xml XML 9531
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 000-22320 | Film No.: 22962574
SIC: 2835 In Vitro & In Vivo Diagnostic Substances